| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.721 | 15.804 | 10.055 | 9.830 | 24.742 | 31.563 | 81.529 | 83.890 | 101.660 | - |
| Total Income - EUR | 17.721 | 15.804 | 10.055 | 9.830 | 24.742 | 31.563 | 81.529 | 84.221 | 102.035 | - |
| Total Expenses - EUR | 10.741 | 12.922 | 7.395 | 11.426 | 15.847 | 25.066 | 60.280 | 76.548 | 82.156 | - |
| Gross Profit/Loss - EUR | 6.980 | 2.881 | 2.660 | -1.596 | 8.896 | 6.497 | 21.249 | 7.673 | 19.879 | - |
| Net Profit/Loss - EUR | 6.449 | 2.582 | 2.357 | -1.694 | 8.648 | 6.181 | 20.499 | 6.847 | 18.879 | - |
| Employees | 1 | 2 | 1 | 1 | 2 | 3 | 6 | 6 | 6 | - |
Check the financial reports for the company - Narkamy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 459 | 13.671 | 9.996 | - |
| Current Assets | 6.707 | 11.608 | 11.530 | 978 | 10.525 | 18.797 | 33.822 | 32.099 | 61.369 | - |
| Inventories | 439 | 435 | 373 | 366 | 359 | 352 | 0 | 0 | 0 | - |
| Receivables | 2.901 | 0 | 0 | 0 | 4.074 | 0 | 42 | 41 | 53.600 | - |
| Cash | 3.367 | 11.173 | 11.157 | 612 | 6.092 | 18.445 | 33.780 | 32.058 | 7.769 | - |
| Shareholders Funds | 5.741 | 4.152 | 1.032 | -681 | 7.980 | 14.010 | 28.639 | 6.785 | 18.976 | - |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | - |
| Debts | 966 | 7.455 | 10.498 | 1.660 | 2.545 | 4.787 | 5.642 | 38.985 | 52.389 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5320 - 5320" | |||||||||
| CAEN Financial Year |
5320
|
|||||||||
Comments - Narkamy S.r.l.